Molecular mechanisms of protein glycosylation and trafficking

蛋白质糖基化和运输的分子机制

基本信息

  • 批准号:
    10655796
  • 负责人:
  • 金额:
    $ 47.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-06-18 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary The objective of this proposal is to gain mechanistic and pathological understanding of protein glycosylation and trafficking. During the previous funding cycle, we have made important contributions to this process. We have determined the structure of the transmembrane domain insertase EMC complex, revealing an elongated cavity in the transmembrane region of the structure that can accommodate a weakly hydrophobic transmembrane helix. We have solved the structures of the protein N-glycosyltransferase (OST) and the protein O-mannosyltransferase Pmt1-Pmt2, revealing the evolutionarily conserved GT-C folds of their catalytic subunits. Protein trafficking requires lipid vesicle formation, a process that is dependent on lipid flippase activity to establish compositional asymmetry between the two leaflets of the bilayer. In this regard, we have determined the structures of all three classes of yeast lipid flippases. This renewal proposal continues our overarching goal to understand protein glycosylation and trafficking. We propose to address two specific knowledge gaps: the structure and mechanism of two protein mannosyltransferases, and how the recently discovered ternary protein complex Arl1-Gea2-Drs2 couples lipid flipping activity with membrane curvature formation, thereby facilitating the downstream vesicle budding process for protein and membrane trafficking. Drs2 is a phosphatidylserine flippase required for the formation of AP-1/clathrin-coated vesicles that travel back and forth between the trans-Golgi network (TGN) and early endosomes. The small GTPase Arl1 is a member of the ADP-ribosylation factor (Arf) family that is activated by the Arf guanine nucleotide exchange factor Gea2. Arl1 operates exclusively in the TGN and is the least well-understood member of the Arf family. We will reconstitute the ternary complex in vitro and perform a comprehensive structure-function study. Protein glycosylation and trafficking is intimately linked to tumorigenesis and cancer progression. Our mechanistic studies will fill these fundamental knowledge gaps, and our derived structures may facilitate the development of small molecules for cancer treatment.
项目摘要 这个建议的目的是获得蛋白质糖基化的机制和病理学的理解 和贩卖人口。在上一个供资周期,我们为这一进程作出了重要贡献。我们 已经确定了跨膜结构域插入酶EMC复合物的结构,揭示了一个延长的 该结构的跨膜区域中的空腔可以容纳弱疏水性的 跨膜螺旋我们已经解决了蛋白质N-糖基转移酶(OST)的结构和 蛋白质O-甘露糖基转移酶Pmt 1-Pmt 2,揭示了其催化的进化保守的GT-C折叠 亚单位。蛋白质运输需要脂质囊泡的形成,这一过程依赖于脂质翻转酶的活性 以在双层的两个小叶之间建立组成不对称性。我们已就此 确定了所有三类酵母脂质翻转酶的结构。这一更新建议继续我们的 总体目标是了解蛋白质糖基化和运输。我们建议解决两个具体问题, 知识缺口:两种蛋白质甘露糖基转移酶的结构和机制,以及最近 发现三元蛋白复合物Arl 1-Gea 2-Drs 2将脂质翻转活性与膜曲率结合 形成,从而促进下游囊泡出芽过程,用于蛋白质和膜运输。 Drs 2是形成AP-1/网格蛋白包被的囊泡所需的磷脂酰丝氨酸翻转酶, 在高尔基体网络(trans-Golgi network,TGN)和早期内体之间来回移动。小型GTALLEY Arl 1是一款 ADP-核糖基化因子(Arf)家族的一员,由Arf鸟嘌呤核苷酸交换激活 因子Gea 2. Arl 1只在TGN中运作,是Arf家族中最不为人所知的成员。 我们将在体外重组三元复合物,并进行全面的结构-功能研究。蛋白 糖基化和运输与肿瘤发生和癌症进展密切相关。我们的机械论 研究将填补这些基本知识的空白,我们的衍生结构可能会促进发展 用于癌症治疗的小分子。

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cryo-EM structures of the endoplasmic reticulum membrane complex.
  • DOI:
    10.1111/febs.15786
  • 发表时间:
    2022-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bai L;Li H
  • 通讯作者:
    Li H
Structure of the human GlcNAc-1-phosphotransferase αβ subunits reveals regulatory mechanism for lysosomal enzyme glycan phosphorylation.
  • DOI:
    10.1038/s41594-022-00748-0
  • 发表时间:
    2022-04
  • 期刊:
  • 影响因子:
    16.8
  • 作者:
    Li, Hua;Lee, Wang-Sik;Feng, Xiang;Bai, Lin;Jennings, Benjamin C.;Liu, Lin;Doray, Balraj;Canfield, William M.;Kornfeld, Stuart;Li, Huilin
  • 通讯作者:
    Li, Huilin
Protein N-glycosylation and O-mannosylation are catalyzed by two evolutionarily related GT-C glycosyltransferases.
Structural basis of the P4B ATPase lipid flippase activity.
  • DOI:
    10.1038/s41467-021-26273-0
  • 发表时间:
    2021-10-13
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Bai L;Jain BK;You Q;Duan HD;Takar M;Graham TR;Li H
  • 通讯作者:
    Li H
Structural insights into the membrane chaperones for multi-pass membrane protein biogenesis.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Huilin Li其他文献

Huilin Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Huilin Li', 18)}}的其他基金

Novel Computational Methods for Microbiome Data Analysis in Longitudinal Study
纵向研究中微生物组数据分析的新计算方法
  • 批准号:
    10660234
  • 财政年份:
    2023
  • 资助金额:
    $ 47.5万
  • 项目类别:
Molecular mechanisms for sorting lysosomal proteins
溶酶体蛋白分选的分子机制
  • 批准号:
    10521596
  • 财政年份:
    2022
  • 资助金额:
    $ 47.5万
  • 项目类别:
Molecular mechanisms for sorting lysosomal proteins
溶酶体蛋白分选的分子机制
  • 批准号:
    10662534
  • 财政年份:
    2022
  • 资助金额:
    $ 47.5万
  • 项目类别:
Biostatistics and Bioinformatics Core
生物统计学和生物信息学核心
  • 批准号:
    10044538
  • 财政年份:
    2020
  • 资助金额:
    $ 47.5万
  • 项目类别:
Biostatistics and Bioinformatics Core
生物统计学和生物信息学核心
  • 批准号:
    10265458
  • 财政年份:
    2020
  • 资助金额:
    $ 47.5万
  • 项目类别:
Structural mechanism of DNA replication
DNA复制的结构机制
  • 批准号:
    10414082
  • 财政年份:
    2019
  • 资助金额:
    $ 47.5万
  • 项目类别:
Structural mechanism of DNA replication
DNA复制的结构机制
  • 批准号:
    10630304
  • 财政年份:
    2019
  • 资助金额:
    $ 47.5万
  • 项目类别:
Structural mechanism of DNA replication
DNA复制的结构机制
  • 批准号:
    10786193
  • 财政年份:
    2019
  • 资助金额:
    $ 47.5万
  • 项目类别:
Structural mechanism of DNA replication
DNA复制的结构机制
  • 批准号:
    10208906
  • 财政年份:
    2019
  • 资助金额:
    $ 47.5万
  • 项目类别:
The structure and function of eukaryotic protein glycosylation enzymes
真核蛋白质糖基化酶的结构和功能
  • 批准号:
    10412104
  • 财政年份:
    2018
  • 资助金额:
    $ 47.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了